GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 111 filers reported holding GOSSAMER BIO INC in Q1 2023. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $75,740 | -82.1% | 34,903 | -1.3% | 0.00% | – |
| Q3 2022 | $423,000 | +44.4% | 35,375 | +0.9% | 0.00% | – |
| Q2 2022 | $293,000 | -11.7% | 35,068 | -8.3% | 0.00% | – |
| Q1 2022 | $332,000 | -26.4% | 38,254 | -4.1% | 0.00% | – |
| Q4 2021 | $451,000 | +5.4% | 39,873 | +17.1% | 0.00% | – |
| Q3 2021 | $428,000 | +59.7% | 34,055 | +2.9% | 0.00% | – |
| Q2 2021 | $268,000 | -28.2% | 33,091 | -17.9% | 0.00% | – |
| Q1 2021 | $373,000 | -57.8% | 40,324 | -55.9% | 0.00% | – |
| Q4 2020 | $884,000 | -16.2% | 91,491 | +7.6% | 0.00% | -100.0% |
| Q3 2020 | $1,055,000 | -2.0% | 85,017 | +2.6% | 0.00% | 0.0% |
| Q2 2020 | $1,077,000 | +166.6% | 82,859 | +107.8% | 0.00% | – |
| Q1 2020 | $404,000 | -46.1% | 39,866 | -17.0% | 0.00% | -100.0% |
| Q4 2019 | $750,000 | +170.8% | 48,005 | +189.9% | 0.00% | – |
| Q3 2019 | $277,000 | +8.2% | 16,557 | +43.4% | 0.00% | – |
| Q2 2019 | $256,000 | – | 11,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |